SAN DIEGO, Aug. 6 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. today announced the pricing of its initial public offering of 27,000,000 shares of its common stock at $15.00 per share, all of which are being sold by the Company. Raymond James & Associates, Inc. is the sole lead book-running manager, with Friedman, Billings, Ramsey & Co., Inc., KeyBanc Capital Markets, a division of McDonald Investments Inc., Legg Mason Wood Walker, Incorporated, and RBC Capital Markets Corporation acting as co- managers. The Company has granted the underwriters an option to purchase up to 4,050,000 additional shares from the Company for the purpose of covering over-allotments, if any.
BioMed Realty Trust, Inc. is focused on acquiring, owning, leasing, managing and selectively developing laboratory and office space for lease to life science tenants, including biotechnology and pharmaceutical companies, scientific research institutes, government agencies and other entities involved in the life science industry. The Company targets properties located in certain markets with established reputations as centers for scientific research, including San Diego, San Francisco, Seattle, Maryland, Pennsylvania, New York/New Jersey and Boston.
The registration statement relating to the common shares has been declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of such common shares in any state in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The offering of these securities will be made only by means of a prospectus, copies of which may be obtained by contacting Raymond James & Associates, Inc., 880 Carillon Parkway, St. Petersburg, FL 33716
BioMed Realty Trust, Inc.
CONTACT: John F. Wilson, II, Chief Financial Officer of BioMed RealtyTrust, Inc., +1-858-485-9840
